menu
    • menu

    Company profile for Nxera Pharma

    NEW Drugs in Dev: 21
    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.

    Virtual Booth

    Contact Supplier

    AbbVie Contract Manufacturing partners globally to develop, scale, and manufacture pharmaceutical products successfully.

    Virtual Booth

    Contact Supplier

    Topscience Biotech is a one-stop supplier of sodium hyaluronate//drug manufacturing license, CEP, GMP, DMF, and Form 41 certifications.

    Virtual Booth

    Contact Supplier

    Zach System is committed to providing Highly Customized Solutions for all your Development Programs.

    Virtual Booth

    Contact Supplier

    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Nxera Pharma is a technology-driven biopharma company focused on developing specialty medicines for patients with unmet medical needs in Japan and globally. The company has built an agile commercial business across Japan and the APAC region, supporting the development and commercialization of innovative therapies. Powered by its proprietary NxWave™ GPCR structure-based drug discovery platform, Nxera Pharma is advancing a str...
    Nxera Pharma is a technology-driven biopharma company focused on developing specialty medicines for patients with unmet medical needs in Japan and globally. The company has built an agile commercial business across Japan and the APAC region, supporting the development and commercialization of innovative therapies. Powered by its proprietary NxWave™ GPCR structure-based drug discovery platform, Nxera Pharma is advancing a strong pipeline both independently and through partnerships with leading pharmaceutical and biotech companies.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Nxera Pharmajapan Flag
    Country
    Country
    Japan
    Address
    Address
    Midtown East, 9-7-2 Akasaka Minato-ku. Tokyo 107-0052
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.nxera.life/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    PEGS Boston Summit

    PEGS Boston Summit

    Not Confirmed

    envelop Contact Supplier

    PEGS Boston Summit

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Nxera's Vamorolone Gains Key DMD Designations in Korea
    Nxera's Vamorolone Gains Key DMD Designations in Korea

    01 Jun 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/06/01/3304800/0/en/nxera-s-vamorolone-granted-key-regulatory-designations-supporting-faster-access-for-duchenne-muscular-dystrophy-patients-in-south-korea.html

    GLOBENEWSWIRE
    01 Jun 2026
    Share Share
    Nxera CEO to Join Fireside Chat at Jefferies NYC Healthcare Conf
    Nxera CEO to Join Fireside Chat at Jefferies NYC Healthcare Conf

    26 May 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/05/26/3300902/0/en/nxera-s-president-ceo-to-participate-in-a-fireside-chat-at-the-jefferies-new-york-healthcare-conference-2026.html

    GLOBENEWSWIRE
    26 May 2026
    Share Share
    Nxera Pharma Out-Licenses GPCR Program, Joins Series A
    Nxera Pharma Out-Licenses GPCR Program, Joins Series A

    11 May 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/05/11/3291564/0/en/nxera-pharma-announces-progress-of-out-licensing-of-gpcr-targeted-program-and-participation-in-series-a-financing.html

    GLOBENEWSWIRE
    11 May 2026
    Share Share
    Nxera Files Patent Suit Over Its miniG Platform Technology
    Nxera Files Patent Suit Over Its miniG Platform Technology

    08 May 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/05/08/3290954/0/en/nxera-files-patent-infringement-action-in-relation-to-its-minig-platform-technology.html

    GLOBENEWSWIRE
    08 May 2026
    Share Share
    Nxera Pharma Q1 2026 Operational Highlights & Results
    Nxera Pharma Q1 2026 Operational Highlights & Results

    01 May 2026

    // FIRSTWORD PHARMA

    https://firstwordpharma.com/story/7259104

    FIRSTWORD PHARMA
    01 May 2026
    Share Share
    Nxera Pharma to Receive $10M Milestone from AbbVie
    Nxera Pharma to Receive $10M Milestone from AbbVie

    20 Apr 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/04/20/3276716/0/en/nxera-pharma-to-receive-us-10-million-milestone-payment-from-abbvie-under-collaboration-targeting-neurological-diseases.html

    GLOBENEWSWIRE
    20 Apr 2026
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search